Bléry M, Delon J, Trautmann A, Cambiaggi A, Olcese L, Biassoni R, Moretta L, Chavrier P, Moretta A, Daëron M, Vivier E
Centre d'Immunologie INSERM/CNRS de Marseille-Luminy, Case 906, 13288 Marseille Cedex 09, France.
J Biol Chem. 1997 Apr 4;272(14):8989-96. doi: 10.1074/jbc.272.14.8989.
Natural killer and T cells express at their surface, members of a multigenic family of killer cell inhibitory receptors (KIR) for major histocompatibility complex Class I molecules. KIR engagement leads to the inhibition of natural killer and T cell activation programs. We investigated here the functional reconstitution of KIR in a non-lymphoid cell type. Using stable transfection in the RBL-2H3 mast cell line, we demonstrated that (i) KIR can inhibit signals induced by FcepsilonRIgamma or CD3zeta polypeptides that bear immunoreceptor tyrosine-based activation motifs; (ii) two distinct immunoreceptor tyrosine-based inhibition motifs-bearing receptors, i.e. KIR and FcgammaRIIB, use distinct inhibitory pathways since KIR engagement inhibits the intracellular Ca2+ release from endoplasmic reticulum stores, in contrast to FcgammaRIIB, which only inhibits extracellular Ca2+ entry; (iii) KIR require co-ligation with an immunoreceptor tyrosine-based activation motif-dependent receptor to mediate their inhibitory function. This latter finding is central to the mechanism by which KIR selectively inhibit only the activatory receptors in close vicinity. Taken together our observations also contribute to define and extend the family of immunoreceptor tyrosine-based inhibition motif-bearing receptors involved in the negative control of cell activation.
自然杀伤细胞和T细胞在其表面表达主要组织相容性复合体I类分子的杀伤细胞抑制受体(KIR)多基因家族的成员。KIR的结合导致自然杀伤细胞和T细胞激活程序的抑制。我们在此研究了非淋巴细胞类型中KIR的功能重建。通过在RBL-2H3肥大细胞系中进行稳定转染,我们证明:(i)KIR可以抑制由携带基于免疫受体酪氨酸的激活基序的FcepsilonRIγ或CD3ζ多肽诱导的信号;(ii)两种不同的携带基于免疫受体酪氨酸的抑制基序的受体,即KIR和FcγRIIB,使用不同的抑制途径,因为与仅抑制细胞外Ca2+内流的FcγRIIB不同,KIR的结合抑制内质网储存中的细胞内Ca2+释放;(iii)KIR需要与基于免疫受体酪氨酸的激活基序依赖性受体共同连接以介导其抑制功能。后一发现对于KIR仅选择性抑制附近激活受体的机制至关重要。我们的观察结果共同有助于定义和扩展参与细胞激活负调控的携带基于免疫受体酪氨酸的抑制基序的受体家族。